25
Participants
Start Date
April 17, 2019
Primary Completion Date
June 19, 2019
Study Completion Date
July 11, 2019
BAY1747846
Single dose; IV injection.
Matching placebo
Single dose; IV injection.
SOUSEIKAI Fukuoka Mirai Hospital, Fukuoka
Lead Sponsor
Bayer
INDUSTRY